[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Multivalent Vaccines Market Data Survey Report 2025

April 2018 | 82 pages | ID: GA49A598823EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Multivalent Vaccines market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
  • Global market size and forecast
  • Regional market size, production data and export & import
  • Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
  • Major Application
  • Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • GlaxoSmithKline, plc (U.K.)
  • Pfizer, Inc. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sanofi Pasteur SA (France)
  • Astellas Pharma Inc. (Japan)
  • CSL Limited (Australia)
  • CSL Limited (Australia)
  • Johnson & Johnson (U.S.)
  • MedImmune, LLC (U.S.)
  • Serum Institute of India Pvt. Ltd. (India)
  • Bavarian Nordic (Denmark)
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Daiichi Sankyo (Japan)
  • Protein Sciences Corporation (U.S.)
  • Panacea Biotec (India)
Major applications as follows:
  • Pediatrics
  • Adults
Major Type as follows:
  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 GlaxoSmithKline, plc (U.K.)
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Pfizer, Inc. (U.S.)
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Merck & Co., Inc. (U.S.)
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sanofi Pasteur SA (France)
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Astellas Pharma Inc. (Japan)
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 CSL Limited (Australia)
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 CSL Limited (Australia)
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Johnson & Johnson (U.S.)
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 MedImmune, LLC (U.S.)
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Serum Institute of India Pvt. Ltd. (India)
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Bavarian Nordic (Denmark)
3.12 Mitsubishi Tanabe Pharma Corporation (Japan)
3.13 Daiichi Sankyo (Japan)
3.14 Protein Sciences Corporation (U.S.)
3.15 Panacea Biotec (India)

4 MAJOR APPLICATION

4.1 Pediatrics
  4.1.1 Overview
  4.1.2 Pediatrics Market Size and Forecast
4.2 Adults
  4.2.1 Overview
  4.2.2 Adults Market Size and Forecast

5 MARKET BY TYPE

5.1 Conjugate Vaccines
  5.1.1 Overview
  5.1.2 Conjugate Vaccines Market Size and Forecast
5.2 Inactivated and Subunit Vaccines
  5.2.1 Overview
  5.2.2 Inactivated and Subunit Vaccines Market Size and Forecast
5.3 Live Attenuated Vaccines
  5.3.1 Overview
  5.3.2 Live Attenuated Vaccines Market Size and Forecast
5.4 Toxoid Vaccines
  5.4.1 Overview
  5.4.2 Toxoid Vaccines Market Size and Forecast
5.5 Recombinant Vaccines
  5.5.1 Overview
  5.5.2 Recombinant Vaccines Market Size and Forecast
5.6 Recombinant Vaccines
  5.6.1 Overview
  5.6.2 Recombinant Vaccines Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline, plc (U.K.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc. (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc. (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi Pasteur SA (France)
Tab Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma Inc. (Japan)
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL Limited (Australia)
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL Limited (Australia)
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of MedImmune, LLC (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Serum Institute of India Pvt. Ltd. (India)
Tab Sales Revenue, Volume, Price, Cost and Margin of Bavarian Nordic (Denmark)
Tab Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma Corporation (Japan)
Tab Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo (Japan)
Tab Sales Revenue, Volume, Price, Cost and Margin of Protein Sciences Corporation (U.S.)
Tab Sales Revenue, Volume, Price, Cost and Margin of Panacea Biotec (India)

LIST OF FIGURES

Fig Global Multivalent Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Global Multivalent Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Global Multivalent Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Multivalent Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Pediatrics Market Size and CAGR 2011-2017 (Million USD)
Fig Pediatrics Market Size and CAGR 2011-2017 (Volume)
Fig Pediatrics Market Forecast and CAGR 2018-2025 (Million USD)
Fig Pediatrics Market Forecast and CAGR 2018-2025 (Volume)
Fig Adults Market Size and CAGR 2011-2017 (Million USD)
Fig Adults Market Size and CAGR 2011-2017 (Volume)
Fig Adults Market Forecast and CAGR 2018-2025 (Million USD)
Fig Adults Market Forecast and CAGR 2018-2025 (Volume)
Fig Conjugate Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Conjugate Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Conjugate Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Conjugate Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Inactivated and Subunit Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Inactivated and Subunit Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Inactivated and Subunit Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Inactivated and Subunit Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Live Attenuated Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Live Attenuated Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Live Attenuated Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Live Attenuated Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Toxoid Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Toxoid Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Toxoid Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Toxoid Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Recombinant Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Recombinant Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Recombinant Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Recombinant Vaccines Market Forecast and CAGR 2018-2025 (Volume)
Fig Recombinant Vaccines Market Size and CAGR 2011-2017 (Million USD)
Fig Recombinant Vaccines Market Size and CAGR 2011-2017 (Volume)
Fig Recombinant Vaccines Market Forecast and CAGR 2018-2025 (Million USD)
Fig Recombinant Vaccines Market Forecast and CAGR 2018-2025 (Volume)


More Publications